Health
The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis – DocWire News
Adv Exp Med Biol. 2021;1321:277-286. doi: 10.1007/978-3-030-59261-5_25.ABSTRACTThere is data from individual clinical trials suggesting that procalcitonin
Adv Exp Med Biol. 2021;1321:277-286. doi: 10.1007/978-3-030-59261-5_25.
ABSTRACT
There is data from individual clinical trials suggesting that procalcitonin (PCT) may be a prognostic factor in the severity of COVID-19 disease. Therefore, this systematic review and meta-analysis was performed to investigate PCT levels in severe COVID-19 patients. We searched Embase, ProQuest, MEDLINE/PubMed, Scopus, and ISI/Web of Science for studies that reported the level of PCT of patient with severe COVID-19….
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business22 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General22 hours agoUK PM ready to ‘shelter’ businesses from tariff storm